Abstract: Tumour cells are characterized by karyotype instability, which is accompanied by specific events in the chromatin structure and epigenetic patterns. Epigenetics involves heritable changes in the physical and biochemical state of chromatin, which have no effect on DNA sequences; therefore, changes in the nuclear radial arrangement of chromosomes can also be considered epigenetic events. Nuclear radial distributions of select genomic regions have been studied in many tumour cells and are not influenced by aberrations in chromosome number. On the other hand, genes involved in translocations take up new positions midway between the original coding sequences. The differentiation of leukaemia cells with clinically used agents is often accompanied by nuclear repositioning of tumour-related genes. However, the nuclear rearrangement is cell-type specific and not always associated with changes in the transcriptional activity. Similarly, cell typespecific chromatin structure is observed in tumour cells treated with select cytostatics and inhibitors of epigenetic processes, which have significant influences on the histone code. Chromatin structure and histone modifications were also affected by gamma radiation in leukaemia, multiple myeloma, and solid tumour cells. Interestingly, gamma radiation induced loci proximity, which has been suggested to increase the probability of exchange aberrations typically associated with tumour progression.
INTRODUCTION
Cancer cells, characterized by inappropriate cell proliferation, altered patterns of differentiation processes, and decreased ability to induce apoptosis, often harbour specific chromosome rearrangements. Multi-step tumourigenesis is a process that results from alterations in DNA-related functions. Genomic changes associated with cancer include gene mutations, chromosome rearrangements, as well as the formation of distinct epigenetic patterns, which lead to changes in gene function without altering the DNA sequence. Important epigenetic alterations that occur during tumourigenesis, particularly in regions containing tumour suppressor genes and oncogenes, include changes in the patterns of DNA methylation, histone modifications, and chromatin structure. Therefore, these nuclear events are crucial targets of anticancer therapies, which often employ inhibitors of the enzymes responsible for implementing epigenetic modifications.
Defining the architecture of interphase chromosomes represents an important challenge for the understanding of chromatin remodeling during tumourigenesis [1, 2] . Interphase chromosomes are composed of hierarchical levels of chromatin loops that, in turn, form the higher-order architecture of chromosome territories (CTs) [3] [4] [5] . Networks of channels that make DNA accessible to regulatory molecules connect the tightly interlaced CTs. Moreover, the 3D-nuclear arrangement of CTs is non-random, as documented by the *Address correspondence to this author at the Institute of Biophysics Academy of Science of the Czech Republic, Královopolská 135, 61265 Brno, Czech Republic; Tel: (+420 5) 41517141; Fax: (+420 5) 41240498; E-mail: bartova@ibp.cz fact that the radial location of genetic elements between the center of the nucleus and the nuclear membrane is specificto, and dependent-on, where the element maps on the metaphase chromosome. The close proximity of some heterologous genetic regions may be responsible for mutual rearrangements, resulting in particular translocations that are associated with the development of many cancers [6] . Moreover, the dynamic properties of chromatin could also provide a mechanism for influencing the formation of cancer-related chromosomal translocations, which likely result from the erroneous joining of two un-repaired double stranded breaks (DSB) [7, 8] . On the other hand, it is interesting that aneuploidy, often related to tumour progression, does not influence the nuclear radial distribution of genomic regions involved in chromosome instability [9, 10] . Moreover, the majority of chromosomes inhabit strikingly similar nuclear layers, defined as center of nucleus-to-locus distance, in normal cells and cancer cells. However, the genetic loci acquire a random distribution inside the nuclear layers [11] . Some chromosomes are polarized, with their genes located in the interior of the nucleus and their centromeres located at the nuclear periphery. In general, the polar and non-polar organization of chromosomes is conserved between different cell types [11] . However, polarity is not conserved for fused genes found on derivative chromosomes [12, 13] . These data strongly support the link between changes in chromatin architecture and tumour development; however, many questions remain unanswered.
Differences in the chromatin arrangement and nuclear morphology can frequently be observed in tumour cells. For example, changes in the radial distribution of translocated loci, changes in the absolute number of nucleoli and in the morphology of nuclear lamina, as well as distinct structural alterations of promyelocytic leukemia (PML) bodies [14] , provide important indicators of tumour cell transformation [12] [13] [14] [15] (Fig. 1) . Moreover, the repositioning of tumourspecific genes within interphase nuclei is an early event in tumourigenesis [16] . Despite the fact that our knowledge of the events that occur to the nuclear architecture of tumour cells has increased, it is not yet apparent whether alterations in the nuclear arrangement are the cause or a consequence of tumourigenesis.
CHANGES IN THE NUCLEAR ORGANIZATION OF TUMOUR CELLS
Chromosomal rearrangement and aneuploidy (Fig. 2) are functionally linked to cancer development, and are accompanied by specific changes in the non-random chromosome organization within intrephase nuclei. Similarly, heterogeneity in the copy number of individual genetic loci has been observed in tumour cells [17] . As expected, the nuclear changes that arise in cancer cells tend to involve chromatinrelated domains that are responsible for the control and regulation of cancer-associated gene expression. Chromosome territories are naturally dynamic structures, and mutual intermingling [18] allows for close contact between neighboring CTs. However, the physical contact between two neighboring chromosomes is what increases the probability of chromosome translocations that are so often found in tumour cells [1, 6, [19] [20] [21] . Using a variety of models for CT interphase distribution, many authors have attempted to define the rules of nuclear arrangement [4, 18, 22] . Despite of the fact that these models represent distinct methodological approaches for CTs visualization, together they try to explain the inter-relationship between CTs and inter-chromatin compartments (IC) and/or between nuclear (territorial) locations of transcriptionally active and inactive loci. Great progress in these studies has been made through the use of fluorescence in situ hybridization (FISH) [23, 24] and high-resolution confocal microscopy. Regardless of the differences in the interphase chromosome models, it is evident that tumour cells are characterized by specific nuclear arrangements of tumour-related genes [16, [25] [26] [27] . For example, the structural parameters of the EWSR1 and FLI1 genes do not differ substantially in G(0)-lymphocytes, stimulated lymphocytes, and Ewing sarcoma cells. However, the fusion genes on derivative chromosomes 11 and 22 in Ewing sarcoma cell nuclei are shifted to the midway position between the native Fig. (1) . An illustration of select nuclear structures in normal and tumour cells. In contrast to normal cells, tumour cells are characterized by an increased number of nucleoli (red) and PML bodies (dark blue). Loci amplification (pink), translocation (white and black), and aneuploidy (yellow) are also frequently observed in the vast majority of tumour cells. Likewise, alterations in the oncoprotein (orange or pastelblue) nuclear/nucleolar distribution pattern are also found in neoplastic cells.
EWSR1 and FLI1 genes. These data imply that the positions of the fusion genes are determined by the final structure of the related chromosomes and not on the location of the translocation event [12, 13] . The frequency of a specific translocation event was also analyzed with respect to the radial positions of the participating chromosomes. This study revealed that loci in close proximity had an increased probability of becoming involved in a translocation event [1, 20] . This is supported by the observation that MYC, BCL2, and IgH loci, which are translocated in various B-cell lymphomas, are preferentially positioned in close proximity to each other in normal B-cells [2] . In general, the frequency of exchange aberrations for a given chromosome is approximately proportional to its total DNA content [28] . However, higherthan-expected frequencies of interchanges, according to the model of linear proportionality, have been calculated for several chromosomes involved in cancer-related translocations. This was specifically observed in certain types of leukemia. In addition, the participation of a large number of chromosomes in exchange aberrations induced by irradiation suggests that, each chromosome within an individual chromatin territory is accessible to several other chromosomes [28] .
An attempt to correlate nuclear radial arrangement and transcriptional activity of tumour-related genes has been published in many studies [16, 26, [29] [30] [31] . However, it was observed that aneuploidy does not change the average nuclear radial location of tumour-associated loci [9, 10] . Conversely, remarkable changes in nuclear radial position arise from translocations [12, 13] , which can positively or negatively influence gene expression [27, 32] . For example, translocation of CCND1 and IgH loci substantially increases CCND1 expression in multiple myeloma cells [32] , while t(13; X) causes silencing of the Rb1 locus in retinoblastoma cells [17] . The importance of the proper regulation of mutual contacts between genes of neighbouring chromosomes is exemplified by the observation that genes from distinct chromosomes use a common transcription factory, the site of RNA polymerase II accumulation [33] [34] [35] . Therefore, current understanding of the functional importance of chromatin structure implicates gene nuclear positioning as a promising diagnostic tool for oncology [5, 14, 36] .
Compared to other tumour suppressor genes and protooncogenes, the c-myc proto-oncogene is a very enigmatic prognostic marker of tumour progression. It can be activated by gene amplification [37] , chromosome translocation [38] , proviral insertion [39] , and retroviral transduction [40] . Cmyc is responsible for cell cycle progression and initiation of differentiation pathways [41] . Significant changes in the intracellular dynamics of c-myc RNA during differentiation were reported by Bains et al. [42] , and specific nuclear and territorial arrangements of active/inactive c-myc genes in human adenocarcinoma HT29 cells was documented by Harni arová et al. [27] . In these experiments, the nuclear arrangements of c-myc genes and transcripts were conserved during cell differentiation and, therefore, were independent of the level of differentiation-specific c-myc (8q24) gene expression. However, after the induction of differentiation, the single copy c-myc gene was found more interiorly within related chromosome territory when compared to c-myc amplicons, which retained the conserved territorial topography [27] . It is interesting that within interphase nuclei gene amplicons are often located more peripherally than the original single copy gene [17, 27, 43] (Fig. 2) . Amplicons are often transcriptionally active [44] and, according to models of chromosome architecture, should be rather positioned towards the center of interphase nuclei. However, the transcriptional activity of amplicons, such as double minute chromosomes (DMs) and homogenously staining regions (HSRs), might be reduced owing to the fact that HSR replicates late in S-phase along with the heterochromatin (summarized by [45] ). This may explain why only a single transcription site of c-myc is observed on both the normal and the derivative chromosome 8 with c-myc gene amplicons found in human colon adenocarcinoma HT29 cells [27, 46] . The peripheral repositioning of HSR might reflect some compensatory cellular process that exists to prevent gene over-expression. Extremely low concentrations of hydroxyurea induce the elimination of DMs and HSRs (arranged in micronuclei) from tumour cell nuclei [17, 47] . Therefore, the peripheral positioning of these structures is advantageous. Solovei et al. [45] have reported that the structures of interphase HSRs are highly expanded compared to the chromosome territories of normal and tumour cells. These authors hypothesized that DMs are located within the interchromosomal domain (ICD) space and that stretches of HSR-chromatin align along this space. Such a topology could facilitate access of amplified genes to transcription and splicing complexes that are assumed to localize to the ICD space [45] .
According to reports in the literature, the c-myc gene and c-myc transcripts have cell type-specific nuclear patterns. This is supported by the fact that colon carcinoma COLO 320DM cells harbouring double minute chromosomes (DMs) have multiple disintegrated c-myc transcription sites [48] , which have also been observed in Sertoli cells, most likely containing normal karyotypes [49] . Conversely, NTERA cells with normal c-myc karyotypes were produced multiple signals representing c-myc transcripts [46] , while HT29 cells that have c-myc in homogenously staining regions (HSR) typically had a single c-myc transcription site. The data described above suggests that c-myc over-expression, observed in many cancer cells, is related to more factors than c-myc karyotype instability which likely plays an important role in early tumourigenesis. Expression of the c-myc gene is regulated by wild-type APC gene activation via the -catenin signalling pathway. Therefore, it has been proposed that either APC mutations or activating -catenin mutations lead to c-myc gene over-expression in colorectal cancers [50] .
An important structural feature of c-myc transcription sites is their association with nucleoli, which correlates well with their central nuclear positioning [27, 46] . Similar observations of c-myc RNA within nucleoli have been published by Bond and Wold [49] and recently by Shimizu et al. [48] ; although, these measurements were not made in three-dimensional space. Moreover, many oncoproteins and tumour suppressor proteins, such as p19, MDM2, IRS, B23, and p53, reside the nucleolus (revised by [51] ). Taking into account the tumour-related changes in the morphology and absolute numbers of nucleoli, these observations implicate the nucleolus as an important structure for growth control, nuclear organization, and cancer development (Fig. 1). 
THE EPIGENETICS OF TUMOUR CELLS
A clear relationship between chromatin architecture and genome function has yet to be established; however, it is evident that tumour cells acquire changes in the morphologies and structures of their nuclear domains (Fig. 1) . In neoplastic cells, a functional relationship between nuclear structure and gene expression is consistent with the epigenetic modifications detected in tumour-related genes. To clarify, DNA methylation and histone post-translational modifications represent the best characterized epigenetic marks, identified in multiple model organisms, as well as in mammals [52] [53] [54] . Here we discuss the epigenetic modifications that arise specifically in tumour cells, which, unlike chromosomal rearrangements and aneuploidy, have the potential to be reversed by anti-cancer therapies.
Genomic DNA hypomethylation was the first epigenetic modification to be described in tumour cells [55, 56] . The global DNA hypomethylation is probably due to an absence of methylation in repetitive sequences in the genome [57] . This event has been linked to the chromosome instability that is associated with tumourigenesis [58] . Histone acetylation and histone methylation are also among the most frequently changed epigenetic marks in human tumour cells.
In both normal and cancer cells, some histone modifications are responsible for the initiation of transcription, while others promote gene silencing [52, 54, 59, 60] . For example, trimethylations at H3K4, H3K36, H3K79, or histone acetylation are responsible for transcriptional activation, while condensed heterochromatin and gene silencing is mediated by H3K9, K3K27, and H4K20 methylations [60] . Distinct epigenetic patterns can be observed in the tumour suppressor genes and protooncogenes of neoplastic cells [61, 62] . As mentioned above, tumour cells are characterized by global DNA hypomethylation; however, increased DNA methylation is frequently observed in tumour-suppressor genes of neoplastic cells [63] . Many specific enzymes are responsible for the appearance of epigenetic marks on N-terminal histone tails which protrude from nucleosomes. For example, histone acetylation involves the recruitment of specific histone acetyl transferases (HATs), while histone deacetylases (HDACs) have the ability to remove this epigenetic mark, which leads to transcriptional repression [52] . This event is accompanied by the activation of H3K9 histone methyltransferases (HMTs), such as SUV39H1, which leads to methylation in histone H3 at lysine 9 (H3K9me) [59, 64] . Methylated H3K9 provides a binding site for heterochromatin protein 1 (HP1) inducing transcriptional repression and heterochromatinization. Although histone methylation has been observed for more than forty years [65] , the enzymes responsible for histone demethylation were discovered recently. Shi et al. [66] were the first to characterize the histone demethylase, called LSD1, which is responsible for H3K4 demethylation. It is well known that H3K4 methylation is associated with transcriptional inactivation, but when LSD1 binds to androgen receptors, it causes demethylation of H3K9 and activates transcription [67] . Other histone demethylases, such as those of the jumonji class (e.g. JHDM2A) [60, 68] , are responsible for H3K9 demethylation (summarized by [60, 69] . However, JHDM1 converts H3K36 dimethylation, an active chromatin mark, to an unmodified state [59] .
The enzymes responsible for other types of histone modifications, such as phosphorylation and ubiquitination, have also been studied with respect to their effects on chromatin structure [70] . Phosphorylation and ubiquitination play important roles in the regulation of transcription, chromosome condensation, DNA repair, and in the induction of apoptosis [71] . For example, in mammalian cells the phosphorylation of histone H3 on Ser10 is associated with transcriptional activation [72] . Similarly, H2A phosphorylation is responsi- Fig. (2) . An example of chromatin and lamin B re-arrangement in tumour cells compared to normal cells. The c-myc gene (red or yellow) is frequently amplified in tumour cells. In this panel, c-myc amplicons were arranged into HSR, which was documented in relationship to the relevant chromosome territory (diffuse green) with the DNA-FISH technique. The presence of the Philadelphia chromosome (Ph) and Ph amplification (yellow) (example from Bártová et al., [43] ) can be observed in chronic myeloid leukaemia (CML); Ph chromosomes involve translocation of bcr and abl genes. Tumour cells are also characterized by aneuploidies, which were detected with the use of alpha satellite centromeric DNA probes and FISH. The nuclei of most normal cells have a regular ellipsoid shape, but irregular shapes can be observed in many cancer cells, as illustrated by the lamin B pattern (right panels).
ble for chromosome condensation [70, 73] . These observations indicate the complexity of the histone modifications that regulate nuclear processes, abnormalities of which are associated with tumourigenesis.
INHIBITORS OF EPIGENETIC PROCESSES IN CANCER THERAPY
As mentioned above, epigenetic alterations may involve covalent modifications of amino acid residues in the histones around which the DNA is wrapped. Such coiled DNA can be methylated in CpG di-nucleotides, referred to as DNA methylation in "CpG-islands". Physiologically, DNA methylation occurs in the promoters of genes and has been associated with heritable gene silencing, but DNA methylation status is frequently changed in tumour cells. DNA methylation and histone modifications are very attractive targets for the development and implementation of new approaches to anticancer therapy [74] . The processes of DNA methylation and histone modifications are mutually interconnected. This is indicated by the fact that methylated DNA is bound by methyl-CpG binding protein (MeCP) complexes that include histone deacetylases (HDACs). The recruitment of HDACs is associated with gene silencing and promotes local chromatin condensation. Complexes of DNA methyltransferase (Dnmt1) with transcriptional repressors, such as retinoblastoma protein 1 (pRb1), provide a direct link between transcriptional regulation and tumour suppression [75] . Tumour development is often associated with an imbalance of HAT a HDAC activity. For example, HDACs are found to be involved in mediating the expression of oncogenic translocation products in some forms of leukemia [76, 77] . Similarly, HDACs associate with the chimeric products of PML-RAR genes in acute promyelocytic leukemia (APL), which supports the conclusion that changes in the level of histone acetylation in tumour cells cause deregulation of tumour suppressor gene and oncogene expression in neoplastic cells [78] . Therefore, inhibitors of HDAC used in combination with inhibitors of Dnmts are promising therapeutic tools. Significantly, the first generation of HDAC inhibitors and DNA methylation inhibitors, such as Zebularine [79] , are currently being used in clinics [80] [81] [82] . For example, Dnmts inhibitors are used to treat myelodysplastic syndrome and prostate cancer [83] [84] [85] . These inhibitors are potent inducers of growth arrest, differentiation, and apoptotic cell death in a variety of transformed cells, owing to their impact on gene expression [78, 86] .
In small lung carcinoma and colon adenocarcinoma cells, it has been observed that histone deacetylase inhibitors, trichostatin A (TSA) and sodium butyrate (NaBt), induce decondensation of interphase chromatin, which is accompanied by an increase in H3K9 and H3(K4) dimethylation, and H3(K9) acetylation [87] . On the other hand, the total levels of heterochromatin protein 1 (HP1) were reduced after HDAC inhibition, which caused the dissociation of HP1 subtypes from centromeric heterochromatin [87, 88] . The effect of TSA and Dnmts inhibitors, such as 5-aza-2'-deoxycytidine (Aza-dC), was also tested in multiple myeloma cells (MM) [89] . In this case, the down-regulation of several MM proliferation-associated genes was observed. However, Aza-dC and/or TSA had the ability to up-regulate other genes, such as CPEB1, CD9, GJA1, BCL7c, GADD45G, AKAP12, TFPI2, CCNA1, SPARC, and BNIP3 [89] . These authors have introduced a new target for aberrant DNA methylation in monoclonal gammapathies and MM and suggest that HDAC and Dnmnts inhibitors have the potential to be useful clinical agents for MM therapy [89] . Moreover, the downregulation of select genes by Aza-dC treatment has also been reported for hepatoma cells [90] , while treatment with TSA results in moderately increased histone H3K9 acetylation at the silenced loci with no effect on histone H3K9 methylation and minimal effect on gene expression. In contrast, Aza-dC rapidly reduces histone H3K9 methylation at the silenced loci, which results in the reactivation of the two select genes [91] . Combination therapy, with Aza-dC and TSA, was synergistic in reactivating gene expression at the loci exhibiting DNA hypermethylation. Histone H3K4 methylation was not affected by TSA treatment, and increased moderately at the silenced loci after Aza-dC treatment [91] . These data document that hypermethylation of DNA in promoter CpG islands is related to transcriptional silencing of tumour suppressor genes, which correlates well with the increased level of histone H3K9 methylation at the promoters studied, for example, in gastric cancer cells [91] . A close interrelationship between DNA methylation and histone epigenetic modifications is also supported by the observation that epigenetic mechanisms regulating gene expression are involved in gastric-and/or hepato-carcinogenesis [92, 93] .
THE EFFECTS OF RADIATION ON CHROMATIN STRUCTURE
A great paradox concerning radiation is its ability to both cause and treat cancer. Therefore, many laboratories have attempted to address how chromatin structure is influenced by UV or gamma-radiation. FISH has proven to be an invaluable technique for the study of chromatin in tumour cells [23, 24] , which when combined with high-resolution confocal microscopy, enables researchers to determine the arrangement of genetic elements within interphase nuclei and the degree of karyotype instability [94, 95] . FISH studies on the nuclear radial arrangement of the tumour suppressor gene, TP53, in leukemia cells have revealed that homologous TP53 genes are repositioned closer to one another and closer to the nuclear center within 2 hours of exposure to gammairradiation. During the next 2-3 hours, the spatial relationship between the TP53 genes returned to the pre-irradiation condition [25, 96, 97] . The exact mechanism of this structural response to gamma-radiation is unknown, but it may be related to DNA repair processes [96] . Radiation primarily induces the formation of DSBs and the DNA repair pathways preferentially mend DSBs in low-density chromatin [98] . Moreover, extensive chromatin de-condensation in close proximity to DSBs, as detected by decreased intensity of chromatin labeling, increased H4K5 acetylation, and decreased H3K9 dimethylation, was observed within 15 min of irradiation [98] . In contrast, only slight movements of sporadic DSB loci, which were also associated with chromatin de-condensation, were observed in untreated cells [98] . Un-repaired or aberrantly repaired radiation damage in mammalian chromosomes can result in the formation of a micronucleus at the first cell division. This results in the loss of genetic information which may lead to cell death. Not all chromosomes in the human genome are equally susceptible to loss by micronucleus encapsulation. Radiation-induced micronuclei have similar structural characteristics to the main nucleus. Moreover, chromosome damage and/or repair after ionizing radiation may be non-random, and micronucleus formation may reflect this variability [99] . Elimination of over-expressed sequences by the formation of micronuclei has been observed for genes arranged in HSR, which is often located at the periphery of interphase nuclei [17, 27, 43] .
The phosphorylated histone 2A family member X (gamma-H2AX) is an important marker for the recognition of DSBs [100] in the study of clustered lesions within chromatin. Low doses of gamma-radiation and alpha-radiation induce the phosphorylation of H2AX in response to DSB formation. Variation in the rate of H2AX de-phosphorylation at induced foci is dependent on both radiation quality and cell characteristics [101] . Recent studies have revealed that tumour suppressor p53 binding protein 1 (53BP1) also colocalizes with radiation-induced DNA double-strand breaks (DSB) [102] in a dose-dependent manner [103] . The gamma-H2AX levels observed at later intervals after irradiation may represent a reliable measure of the overall DSB repair capabilities. The use of this parameter as a predictor of sensitivity to radiation is dependent on p53 status [104] . The formation of DNA DSBs plays an important role in the genomic instability inherent in the majority of human cancer cells. In precancerous lesions, these DNA DSBs activate p53, which, by inducing apoptosis or senescence, raises a barrier to tumour progression. Disruption of this barrier through various mechanisms, most notably mutation of p53, allows tumours to develop. Thus, oncogene-induced DNA damage may explain two key features of cancer: genomic instability and the high frequency of p53 mutations [105] . Moreover, DNA damage and senescence markers are frequently observed in precancerous lesions. Thus, senescence in human pre-neoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression [106] .
The consequences of DSBs are higher-order chromatin rearrangements, particularly because non-repaired DSBs increase the probability of chromosome translocations [7, 107, 108] . Therefore, the physical distance between individual genetic elements is an important factor in the processes that lead to the translocations that are responsible for oncogenic transformation [1] . Moreover, chromatin radial arrangement is also influenced by the mobility of given chromatin domains. For example, local diffusion of chromatin is important for gene regulation, while global chromatin immobility is involved in the maintenance of genomic stability [7] . However, broken ends of chromosomes are apparently positionally stable. This phenomenon requires the DNA-end binding protein Ku80, but is independent of DNA repair factors, gamma-H2AX, and the cohesion complex. DSBs preferentially undergo translocations with neighboring, spatially proximal DSBs and loss of local positional control leads to increased genomic instability [8] .
ALTERED CHROMATIN-ASSOCIATED NUCLEAR DOMAINS IN TUMOUR CELLS
The structural and functional compartmentalization of the mammalian interphase nucleus has been investigated by many laboratories. These studies have revealed that, in addition to chromosome territories, the nucleus contains chromatin-associated domains, such as nucleoli, nuclear speckles, transcription factories, PML, Cajal bodies, and others (summarized by [3, 4] ) (Fig. 3) , which are frequently altered in tumour cells [51] . The number and size of nucleoli is frequently increased in neoplastic cells [109, 110] , an early indication of tumour cell transformation [51] . Physiologically, the nucleolus is a site of ribosomal gene expression and represents one of the cell's largest transcription factories (Fig. 1) . The nucleolus is the most prominent example of sub-nuclear compartmentalization [111, 112] , similarly to the individual interphase chromosome territories [4] . Three major sub-structures of nucleoli can be distinguished: the fibrillar center (FC); the granular component (GC), and the dense fibrillar component (DFC). The FC contains ribosomal rDNA genes and some of the essential components of polymerase I (Pol I) transcription machinery. The DFC forms a region around the FC and contains a high concentration of ribonucleoproteins; and therefore, this area is especially electron-dense [113] . Transcription of rDNA genes frequently occurs in the boundary between the FC and DFC [114] . The third region, called the GC, is a nucleolar sub-compartment where the later steps of pre-rRNA processing take place. The periphery of nucleoli is composed of DNA of five acrocentric chromosomes (13-15, 21, and 22) [115, 116] and these regions are called NORs (Nucleolar Organizer Regions) [117, 118] . The NORs, consisting of 5.8S, 18S, and 28S rRNA and NOR-bearing chromosomes, are thought to be regularly associated with the nucleolus [117] [118] [119] . In metabolically active mammalian cells, the nucleolus contains tens to hundreds of active ribosomal genes (approximately 400), which have a high level of transcriptional activity [112] . The activity of rDNA genes can be regulated at the level of the entire NOR region [120, 121] and expression of individual ribosomal genes within a given NOR can be studied in DNA spreads, called "Christmas trees" [122] . Moreover, the relationship between NORs and the structure of related chromosome territories seems to be important with respect to nucleolus function [123] . Detection of disorders in NOR regions have proven to have clinical significance. For example, the number of nuclei-related AgNORs (argyrophilic nucleolar organizer region) correlates with tumour grade [124] . Moreover, AgNOR scores in bladder carcinoma cells reflect variations in tumour biological behavior, although the clinical value of this technique is still limited [124, 125] . However, other reports claim that AgNORs score is an excellent index for determining the tumour grade [126, 127] .
Chromatin-associated domains such as transcription factories, nuclear speckles, promyelocytic leukemia bodies, Cajal bodies, and other proteinaceous structures (Fig. 3) par-ticipate in the regulation of transcription and splicing [3, 4, 128] . Promyelocytic leukaemia nuclear bodies (PML NBs) are one of the chromatin-associated structures responsible for regulating transcription, programmed cell death, tumour suppression, and antiviral defense. Mammalian nuclei contain 10 -30 spherical PML NBs [129] [130] [131] , which consist of several proteins, including PML and Sp100. Interest in these nuclear bodies has increased significantly with the observation that, in acute promyelocytic leukaemia (APL), the gene encoding PML is fused to the retinoic acid receptor alpha (RAR ) gene, forming a t(15;17) translocation [132] [133] [134] [135] [136] . Therefore, PML bodies are nuclear organelles that are associated with various diseases and especially with leukemia [137] . Moreover, the importance of the tumour suppressor PML protein has been indicated in the pathogenesis of various cancers [138] . In APL patients treated with all-trans retinoic acid, remission is accompanied by restoration of the PML body nuclear compartment, which is associated with competency of cells for physiological differentiation [132, 136] . This process is also accompanied by a reduction in the number of PML nuclear bodies [139] . A reduced number of PML NBs is associated with their repositioning closer to the nuclear interior, which is thought to be important for nuclear processes, such as transcription and splicing [14, 27, 139] . Conversely, an increased number of PML bodies is specifically observed in cells treated with cytostatics. In this case, the cytostatics additionally cause the PML bodies to be redistributed closer to the nuclear periphery [139] . These data indicate that the PML NBs play an important role in tumourigenesis, and that they can be re-arranged to a normal physiological state after anti-cancer therapy. Thus PML bodies, their proteins, and post-translational sumoylation of PML [140] may be promising tools in tumour diagnosis and therapy.
FUTURE PERSPECTIVES
It is evident that the main focus of studies on tumour cell biology is heading towards an understanding on how gene expression is regulated by transcription factors, chromatin structure, and epigenetic processes. A major interest will be the clinical applications of inhibitors of enzymes responsible for epigenetic modifications of DNA and histones, which in contrast to genomic instability, should be reversible in tumours cells. Through the use of these agents, expression of tumour suppressors and proto-oncogenes can be regulated, which will lead to a better mechanistic understanding, as well as an understanding of therapeutic methods that are based on the suppression of tumour cell proliferation. From a diagnostic point of view, assays that measure relevant protein levels, as well as their nuclear and cellular distributions, could be more regularly applied in clinics. At present, several methods are proving to be indispensable in the study of tumourigenesis, especially those that use microarray technologies to analyze a large amount of genes. Use of these technologies will uncover the genetic and epigenetic profiles that are distinct in neoplastic cells, when compared with the corresponding patterns in normal tissues. 
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